If a supplement bottle says it “supports” GLP-1 activity, that word is doing very specific legal work — and it is not a promise that the product acts like a GLP-1 medication. This guide walks through what label and marketing language is actually allowed to claim, what it cannot claim, and gives you a short worksheet to run any GLP-1-adjacent product through before you buy. This article is independent educational content; it does not provide medical care, and it does not replace a conversation with your prescriber or pharmacist.
What a Supplement Label Is Legally Allowed to Say
Dietary supplements are regulated differently from prescription drugs. Under the Dietary Supplement Health and Education Act (DSHEA), manufacturers and distributors are responsible for evaluating their own products' safety and labeling before they go to market — the FDA does not pre-approve a supplement or its claims. The agency's enforcement role mostly begins after a product is already for sale, when it can act against items that are adulterated or misbranded.
The claims you see on a label typically fall into a category called a “structure/function claim” — a statement that an ingredient supports the body's normal structure or function (for example, “supports healthy blood sugar already in the normal range” or “supports appetite balance”). A structure/function claim is different from a disease claim, which would say a product diagnoses, treats, cures, or prevents a specific disease — supplements are not permitted to make disease claims. Whenever a structure/function claim appears, federal rules require this exact disclaimer in boldface on the label: “This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.” If you don't see that language, or it's tucked away in tiny print, treat that as a flag worth noting on the worksheet below.
Why “GLP-1 Support” Is Not the Same as a GLP-1 Medication
GLP-1 receptor agonists (the drug class that includes prescription medications for diabetes and weight management) are prescription drugs that went through FDA's drug approval process, with clinical trial data reviewed before they reached the market. A dietary supplement is a different legal category entirely — it does not contain a GLP-1 receptor agonist drug molecule, and no supplement ingredient has been through that same premarket review for effectiveness at treating a condition.
When label or ad copy borrows drug-adjacent phrasing — “natural Ozempic,” “GLP-1 alternative,” “boosts your own GLP-1” — that is marketing language describing an ingredient's theorized effect on the body's own systems, not a claim that has been through the same evidence bar as an approved medication. It's worth reading that kind of phrasing the way you'd read any comparison: as a claim that needs its own support, not as a fact.
A separate, related category is compounded semaglutide or tirzepatide sold through some telehealth clinics. Compounded drugs are not FDA-approved — the agency states plainly that it does not review their safety, effectiveness, or quality before they're marketed, and it has continued to investigate adverse events tied to contaminated or poor-quality compounded products. That is a different risk profile from an over-the-counter supplement, but the common thread is the same: “not reviewed by FDA before sale” applies to both compounded GLP-1 drugs and GLP-1-support supplements, for different regulatory reasons.
The Claim and Label Audit Worksheet
Keep the product's label and its sales page open side by side, and work through these questions. None of them requires special training — they're about what the words in front of you actually say versus what they imply.
- Is the required disclaimer present and legible? Look for the boldface statement that the claim hasn't been evaluated by the FDA and that the product isn't intended to diagnose, treat, cure, or prevent disease. Its absence, or burial in fine print, is worth noting.
- Does the claim name a body function, or does it name a disease? “Supports healthy blood sugar already in the normal range” is a structure/function claim. “Treats” or “reverses” a diagnosed condition is a disease claim a supplement isn't permitted to make.
- Does the marketing compare the product to a named prescription drug without data behind it? Phrases like “natural alternative to [drug]” are comparative claims. Check whether any study is cited, and whether that study tested this exact finished product or just one ingredient in isolation.
- Whose research is being cited — the finished product, or one ingredient? A study on an isolated ingredient (say, berberine or a fiber source) at a specific dose doesn't automatically mean the finished product, at whatever dose it actually contains, produces the same effect.
- Are ingredient amounts disclosed, or hidden inside a “proprietary blend”? A full ingredient panel with amounts lets you compare the product to the studies it cites. A blend that hides individual amounts makes that comparison impossible.
- Are results presented as typical, or as best-case? Testimonials, before/after photos, or “results may vary” language next to dramatic claims are worth weighing against the absence of your own clinical data on the product.
- Is there any mention of interaction risk with prescription medications? Most dietary supplements have not been studied for interactions with GLP-1 medications, blood sugar medications, or other prescriptions — silence on this point isn't the same as “no interaction.”
- Can you identify who stands behind the product? A named manufacturer or distributor with real contact information is a baseline transparency signal; its absence is not proof a product is unsafe, but it removes a layer of accountability.
None of these questions tells you whether a product will “work” for you personally — they tell you whether the claims in front of you are the kind a label is legally allowed to make, and whether the evidence offered actually matches what's being claimed.
Who Should Talk to a Clinician or Pharmacist First
Bring the worksheet and the product label to a pharmacist or your prescriber before starting a GLP-1-support supplement if any of the following apply to you: you are currently taking a prescription GLP-1 medication or another diabetes or weight-management drug; you take other prescription medications, since supplement-drug interactions are often unstudied rather than confirmed safe; you are pregnant, nursing, or managing a chronic condition such as diabetes, thyroid disease, or a GI disorder; or you have had a reaction to a supplement ingredient before. A pharmacist can check the ingredient list against your medication list in a way a product label cannot.
What You Can Do Next
Work through the worksheet with the actual label in hand rather than relying on the sales page alone, since the two don't always say the same thing. If you want a closer look at what's commonly inside these products and whether the ingredient-level research holds up, our review of what GLP-1 supplements actually contain breaks down specific ingredients and brands against the claims made for them. If a claim still seems off after you've gone through the worksheet, your pharmacist or prescriber is the most reliable next stop — and if you believe a product's marketing is misleading, that's the kind of concern the FDA and FTC take reports on directly.
Sources
- U.S. Food and Drug Administration — Dietary Supplements
- U.S. Food and Drug Administration — Structure/Function Claims
- U.S. Food and Drug Administration — Understanding the Risks of Compounded Drugs
This article is for general educational purposes and reflects publicly available FDA guidance as of the date below. It is not medical advice, and no clinician has reviewed this specific draft. For guidance about your own health or medications, talk to a licensed healthcare professional. See our Medical Disclaimer for more detail. This page may contain affiliate links as described in our Affiliate Disclosure; the link above to our GLP-1 supplements review is an editorial reference, not a paid placement.
Last fact-checked: October 1, 2026.